Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Therapeutic Drug Monitoring|March 3, 2022
What Is the Therapeutic Reference Range for Levetiracetam? Grand Round/A Case StudySylvain Couderc, Mondher Chouchane, Franck Saint-MarcouxTherapeutic Drug Monitoring|November 15, 2017
Unsuccessful Suicide Attempt With TiaprideSylvain Couderc, Hervé Mourou, Caroline Monchaud, et al.Therapie|February 8, 2021
[Therapeutic drug monitoring of antidepressants: Why venlafaxine is the most monitored drug? A review of literature]Sylvain Couderc, Celine Mory, Léa Darnaud, et al.Fundamental & Clinical Pharmacology|February 16, 2018
Infectious risk of biological drugs vs. traditional systemic treatments in moderate-to-severe psoriasis: a cohort analysis in the French insurance databaseSylvain Couderc, Maryse Lapeyre-Mestre, Robert Bourrel, et al.Therapie|February 28, 2022
[Therapeutic drug monitoring of cyamemazine: How to interpret a concentration? A review of literature]Hugo Alarcan, David Schnell, Stéphane Rouleau, et al.British Journal of Clinical Pharmacology|November 14, 2018
Self-poisoning with 60 tablets of Apixaban, a pharmacokinetics case reportBénédicte Franck, Sylvain Dulaurent, Souleiman El Balkhi, et al.Therapeutic Drug Monitoring|December 30, 2023
A Massive Venlafaxine Intoxication: Evolution of Cardiac Toxicity with Venlafaxine and O-Desmethylvenlafaxine Elimination Kinetics: A Grand RoundSylvain Couderc, Anthony Gabriel, Sarah Decheiver, et al.Pageof 1